rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
1994-12-12
|
pubmed:abstractText |
Chemotactic activity of granulocytes attracted by tumor cells loaded either with anti-ganglioside monoclonal antibodies (mAb) or with antibody-glucose oxidase conjugates (mAb-GO) was investigated. The melanoma cell line SK-Mel-28 which expresses the ganglioside GD3 at high density as well as the neuroectodermal cell line SK-N-LO which expresses GD2 were used for the experiments. In the presence of 50% human AB-serum, antibody-loaded tumor cells induced chemotactic activity on granulocytes, probably due to the generation of C3a/C5a which could be detected in serum incubated with anti-GD3 loaded SK-Mel-28 cells. Both compounds could also be detected in vivo in the plasma of patients suffering from neuroblastoma during therapy with anti-GD2 antibodies. In another set of experiments mAb-GO conjugates generating high amounts of H2O2 in the presence of glucose were bound to these tumor cells. A significant lipid peroxidation could be observed in the simultaneous presence of iron and ascorbate. The lipid peroxidation products were measured as thiobarbituric acid-reactive substances (TBARS) and were also shown to induce chemotactic effects on granulocytes.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/ABO Blood-Group System,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Chemotactic Factors,
http://linkedlifedata.com/resource/pubmed/chemical/Complement C3a,
http://linkedlifedata.com/resource/pubmed/chemical/Complement C5a,
http://linkedlifedata.com/resource/pubmed/chemical/Gangliosides,
http://linkedlifedata.com/resource/pubmed/chemical/Glucose Oxidase,
http://linkedlifedata.com/resource/pubmed/chemical/Hydrogen Peroxide,
http://linkedlifedata.com/resource/pubmed/chemical/ganglioside, GD2,
http://linkedlifedata.com/resource/pubmed/chemical/ganglioside, GD3
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0165-2478
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
41
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
67-71
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7959905-ABO Blood-Group System,
pubmed-meshheading:7959905-Antibodies, Monoclonal,
pubmed-meshheading:7959905-Chemotactic Factors,
pubmed-meshheading:7959905-Chemotaxis,
pubmed-meshheading:7959905-Complement C3a,
pubmed-meshheading:7959905-Complement C5a,
pubmed-meshheading:7959905-Gangliosides,
pubmed-meshheading:7959905-Glucose Oxidase,
pubmed-meshheading:7959905-Granulocytes,
pubmed-meshheading:7959905-Humans,
pubmed-meshheading:7959905-Hydrogen Peroxide,
pubmed-meshheading:7959905-Lipid Peroxidation,
pubmed-meshheading:7959905-Melanoma,
pubmed-meshheading:7959905-Neuroectodermal Tumors,
pubmed-meshheading:7959905-Tumor Cells, Cultured
|
pubmed:year |
1994
|
pubmed:articleTitle |
Chemotactic activity of substances derived from antibody-loaded tumor cells on granulocytes.
|
pubmed:affiliation |
Department of Dermatology, Children's Hospital, Tuebingen, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|